ACHIEVE LIFE SCIENCES INC. - COMMON SHARES

Achieve Life Sciences to Announce First Quarter Financial Results and Host Conference Call and Webcast on May 9, 2024

25 4 2024 07:00:00 提供 Nasdaq GlobeNewswire

Achieve Life Sciences to Present at Life Science Innovation Northwest 2024 Conference

11 4 2024 07:00:00 提供 Nasdaq GlobeNewswire

Achieve Life Sciences Reports Financial Results for Fourth Quarter and Year-End 2023 and Provides Corporate Update

28 3 2024 15:01:21 提供 Nasdaq GlobeNewswire

Achieve Life Sciences Announces Data from Cytisinicline ORCA Program to be Presented at the 2024 Society for Research on Nicotine and Tobacco (SRNT) Annual Meeting

20 3 2024 07:00:00 提供 Nasdaq GlobeNewswire

Achieve Life Sciences to Announce Fourth Quarter and Year-End 2023 Financial Results and Host Conference Call and Webcast on March 28, 2024

14 3 2024 07:00:00 提供 Nasdaq GlobeNewswire

Achieve Life Sciences Announces Participation at Upcoming Investor Conferences

06 3 2024 07:00:00 提供 Nasdaq GlobeNewswire

Achieve Life Sciences Reaches Agreement with the FDA on Long-Term Cytisinicline Exposure Data Requirements for NDA Submission

29 2 2024 07:01:00 提供 Nasdaq GlobeNewswire

Achieve Life Sciences Announces Pricing of up to $124.2 Million Registered Direct Offering and Concurrent Private Placement

29 2 2024 07:00:00 提供 Nasdaq GlobeNewswire

Achieve Life Sciences Announces Participation at Upcoming Investor Conferences

11 12 2023 15:30:00 提供 Nasdaq GlobeNewswire

Achieve Life Sciences Reports Financial Results for Third Quarter and Provides Corporate Update

09 11 2023 15:00:00 提供 Nasdaq GlobeNewswire

Achieve Life Sciences to Announce Third Quarter 2023 Financial Results and Host Conference Call and Webcast on November 9, 2023

26 10 2023 07:00:00 提供 Nasdaq GlobeNewswire

Achieve Life Sciences Announces Participation at Upcoming Investor Conferences

03 10 2023 07:00:00 提供 Nasdaq GlobeNewswire

Achieve Life Sciences Announces Presentation of Cytisinicline E-Cigarette Cessation (ORCA-V1) Results at Society for Research on Nicotine and Tobacco Europe (SRNT-E) Annual Meeting

11 9 2023 07:00:00 提供 Nasdaq GlobeNewswire

Achieve Life Sciences Announces Participation at Upcoming Investor Conferences

07 9 2023 07:00:01 提供 Nasdaq GlobeNewswire

Achieve Life Sciences Reports Financial Results for Second Quarter 2023 and Provides Corporate Update

14 8 2023 15:00:00 提供 Nasdaq GlobeNewswire

Achieve Life Sciences to Announce Second Quarter 2023 Financial Results and Host Conference Call and Webcast

01 8 2023 07:00:01 提供 Nasdaq GlobeNewswire

Achieve Life Sciences Announces Presentation at 2023 American Society of Pharmacognosy Annual Meeting

18 7 2023 07:00:01 提供 Nasdaq GlobeNewswire

Achieve Life Sciences Announces Publication of Cytisinicline Phase 3 ORCA-2 Smoking Cessation Trial in Journal of the American Medical Association (JAMA)

11 7 2023 10:23:26 提供 Nasdaq GlobeNewswire

Achieve Life Sciences Announces Participation at Upcoming Investor Conferences

06 6 2023 07:00:01 提供 Nasdaq GlobeNewswire

Achieve Life Sciences Announces Pricing of $16.5 Million Registered Direct Offering

25 5 2023 08:00:00 提供 Nasdaq GlobeNewswire